Money Info Show

Investment News Show

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

 

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

Money Info is hosted by Mike King and Charles Moskowitz.

Watch Money Info

Investment News Show Replays

October 21, 2014 Show:

OTC Stock Market News Today

Investing News Show

The October 21, 2014 Money Info OTC Stock Market News Today show will feature live interviews with:

Jason Paltrowitz, managing director of business development for the OTC Markets group will be on from 10:12 to 10:27

and

Rachel Levine will be our guest from 10:35 to 10:55

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show

LISTEN LIVE

Use this Link To Watch The Show:

www.princetonresearch.com/money-info-live.htm

Be On The Air With Us
Call In Your Questions
888-792-1590

Jason Paltrowitz, managing director of business development for the OTC Markets group will be on from 10:12 to 10:27

OTC Stock News

See website: http://www.otcmarkets.com

See Facebook Page: https://www.facebook.com/OTCMarkets

Jason Paltrowitz is the Managing Director and Global Head of Business Development at OTC Markets Group. Mr. Paltrowitz joined the company on October 2013 after serving more than two years as a Managing Director and Segment Head at JP Morgan Chase & Co. where he managed the custody, clearing and collateral management business in the Corporate and Investment Bank division.

Prior to that, he held several senior management positions at Bank of New York Mellon Corp. Mr. Paltrowitz was also a member of the board of directors at OTC Markets Group from 2008 to 2011 and helped launch the OTCQX marketplace PAL offering for ADR issuers at Bank of New York Mellon.

OTC MARKETS

Three Tiered Marketplaces

The OTC Markets are Open, Transparent and Connected financial marketplaces that provide investors with the information necessary to intelligently analyze, value and trade 10,000 U.S. and global securities through the broker of their choice.

To create clarity in the investment process, we organize these securities into three tiered marketplaces – OTCQX, OTCQB and OTC Pink – based on the quality and quantity of information the companies make available.

OTC Stock Market News

Figures are for October 21, 2014 9:30 EDT

OTCQX Logo

The Best Marketplace

The OTCQX® best marketplace is for established investor-focused U.S. and global companies. To qualify for the OTCQX marketplace, companies must meet high financial standards, demonstrate compliance with U.S. securities laws, be current in their disclosure, and be sponsored by a professional third-party advisor. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.

OTCQB Logo
The Venture Marketplace

The OTCQB® venture marketplace is for entrepreneurial and development stage U.S. and international companies that are unable to qualify for OTCQX. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. However, since there are no minimum financial standards other than a $0.01 bid test, companies will vary in their financial strength.

OTC Pink Logo
The Open Marketplace

The OTC Pink® marketplace offers trading in a wide spectrum of equity securities through any broker. This marketplace is for all types of companies that are there by reasons of default, distress or design, which is why they are further sub-categorized by the levels of information that they provide.

Investment News Show

Listen to the second hour of the show for:

Rachel Levine Vice President, Investor Relations for

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Radiation Exposure Treatment Medical Stocks To Buy

 

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

Innovative Drugs To Treat Cancer

Buffalo, NY – September 3, 2014 – Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced that the minutes from its meeting with the U.S. Food and Drug Administration (FDA) in July confirmed that the Company’s existing efficacy and safety data and animal-to-human dose conversion are sufficient to proceed with a pre-Emergency Use Authorization (pre-EUA) submission for entolimod for reducing the risk of death following exposure to potentially lethal irradiation occurring as the result of a radiation disaster.

See more at:

http://www.princetonresearch.com/medical-stock-news-cbli/

Small cap medical stocks

Radiation Exposure Treatment Drugs

Stock News

Just imagine the catastrophe if radioactive material falls into the wrong hands. The Russians have invested heavily in this.  CBLI is involved in the development of Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment, and Curaxin CBL0137, the lead oncology product candidate.

The company conducts business in the United States and in the Russian Federation through our three operating subsidiaries, Incuron, LLC, BioLabs 612, LLC and Panacela Labs, Inc. The company maintains strategic relationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia.

To learn more about Cleveland BioLabs, Inc., please visit the Company’s website at http://www.cbiolabs.com.

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

See news

 

October 14, 2014 Show:

The October 14th Money Info investing news show will feature a live interview with small cap mining stock to buy:

XIMEN MINING CORP 

Stock Symbol: XIM On VSX

XXMMF on OTCQX

Christopher R. Anderson, President, CEO and Director

See corporate site:  http://ximenminingcorp.com

Get XIM stock quote, trading chart and latest news:

http://ximenminingcorp.com/investors/

Mining Stocks To Buy

Like and Follow

Small Cap Mining Stock

Ximen Mining Corp. on their Facebook Page 

Ximen Mining Corp is in the business of sourcing, exploring, developing and evaluating precious metal assets in British Columbia, Canada.

The Company currently has a 100% interest in two properties: the Gold Drop Project and the Brett Gold Project – See More.

Mr. Anderson has over 25 years of business experience with an emphasis on strategic planning, communications, and creative marketing. He has been instrumental in facilitating several millions of dollars in financing for both public and private enterprise with a recent focus on the mineral exploration industry.

mining stocks to buy

Small Cap Mining Stock NEWS

Ximen Begins Drilling Second Target Area — Brett Gold Property, Vernon, BC – See News

OCT-8-2014 DRILL PROGRAM TESTING THREE NEW TARGET AREA’S — See News

XIMEN’S FIRST FOUR DRILL HOLES TARGET NEW HIGH GRADE ZONE BELOW THE MAIN SHEAR ZONE — See News

gold mining stocks to buy

The Gold Drop property that is located 40 km from Grand Forks British Columbia in geologically prospective ground in the well-mineralized Greenwood District, and has a phase 1 exploration permit which enables the company to establish up to 20 drill sites and up to 25 excavator trenches on the property and is valid until Dec. 1, 2018.

The Brett property located near Vernon BC in one of the largest gold-bearing epithermal systems in Southern B.C. The property has a area-based notice of work permit for surface exploration, covering excavator trenching and diamond drilling (22 drill sites and up to 35 drill holes) valid until Sept. 17, 2016.

best gold mining stocks

CORPORATE PRESENTATION — Click Here

XIMEN MINING FACT SHEET — Click Here 

October 7, 2014 Show:

Small Cap Stocks To Buy

The October 7, 2014 show featured a live interview with

Ryan Schadel, Chairman, Chief Executive Officer of Labor Smart, Inc.

Stock Symbol: LTNC

 

Listen to Part 1 of the show:

Investing News Show On

Where To Invest In October 2014

 

Listen to Part 2 of the show with Labor SMART CEO interview:

Money Info Investing News Show October 7, 2014 Small Cap Stocks To Buy Part 2

Money Info

Investing News Show

October 7, 2014

Small Cap Stocks To Buy

See Show News:

http://www.prlog.org/12379856-small-cap-stocks-to-buy-investment-news-show-to-feature-labor-smart-ltnc-ceo-interview-live.pdf

Small cap stock news

See corporate site: http://www.laborsmart.com

See Investor Information Page: http://client.irwebkit.com/Laborsmart

Get Yahoo Finance LTNC quote, charts and news:

http://finance.yahoo.com/q?s=LTNC

 

See Show News: http://www.prlog.org/12379856-small-cap-stocks-to-buy-investment-news-show-to-feature-labor-smart-ltnc-ceo-interview-live.pdf

 

Labor SMART is a provider of on-demand temporary labor solutions, providing manpower to small and medium sized businesses in the warehouse, light industrial, construction, events and retail industries.

Labor Smart, Inc currently operates 30 branch locations in the Southeast and Central U.S.

stocks to buy October 2014

Ryan Schadel, is the Labor Smart founder, sole officer and a director. He has nearly 13 years’ experience in the temporary staffing industry. During these 12 years he has held numerous positions, starting as  sales rep in January 2000 with a nationwide temporary staffing company. Of his nearly 13 years’ experience in the industry, 11 have been in a management or executive capacity, and 8 of those years in a multi-unit management capacity.

Labor SMART: Your Home for

Skilled, Dedicated, On-Demand Temp Labor Services

A leader in providing temporary labor, LTNC specializes in serving the needs of the following industries:

  • Construction
  • Restoration
  • Hospitality
  • Events
  • Retail
  • Manufacturing
  • Warehousing
  • Demolition

See more at:

http://www.laborsmart.com/services/

 

Stocks to buy October 2014 NEWS

LABOR SMART ACQUIRES KWIK JOBS — 

Labor Smart Inc. (OTCBB: LTNC), a provider of industrial staffing serving the southeastern US, acquired the operating assets of Kwik Jobs Inc. and its two branches located in Alabama and Georgia. Kwik Jobs targets general contractors and related companies.

See more at: http://www.staffingindustry.com/Research-Publications/Daily-News/Labor-Smart-acquires-Kwik-Jobs-31636

The acquisition is expected to add between $2 million and $2.7 million in revenue in 2015.

Labor Smart has reported second-quarter revenue of $6.4 million in April, up from $4.0 million in the second quarter of last year.

The firm has 31 branch offices and provides skilled and unskilled labor.

 

Are You Ready for Some Football?

Labor SMART Scores Touchdown

Company to Provide Hundreds of Employees for Game Day

 SEE NEWS:

http://money.cnn.com/news/newsfeeds/articles/marketwire/1142425.htm

Labor SMART, Inc. (OTCQB: LTNC) a leader in providing on-demand blue collar staffing primarily in the southeastern United States, today announced that the Company will be providing employees to assist with event setup, clean up, and concessions at several Pro Football venues this Sunday and beyond.

Ryan Schadel, President and CEO of Labor SMART, commented,

“As your favorite Pro Football team takes the field of battle this Sunday, hundreds of Labor SMART team members will be working behind the scenes with our clients to make game day a success. We have worked with stadiums in the past but this year we are seeing a major expansion of this line of business, not only with Pro Teams directly, but also with a number of vendors who have contracts to provide various services on game day.”

 

Labor SMART, Inc. September Revenue Jumps 29.16% Year-over-Year — Year-to-Date Revenue Exceeds $18,000,000

See News

September 30, 2014 Labor SMART, Inc. announced record September revenues, continuing a long streak of year-over-year increases. The Company also announced that Year-to-Date revenue for 2014 has exceeded $18,000,000.

Company-wide revenue for the four week month ended September 26, 2014 was $2.13 million, a 29.16% increase compared to September 2013 revenue of $1.65 million. Among the 15 branches open one year or more at September 26, 2014 revenue was up 9.25%, affected by the culling of low margin and high risk business in July that represented a year-over-year reduction of $244,230 in revenue during the month of September.

September 30, 2014 Show:

Small Cap Medical Stocks

On Investing News Show

Small Cap Medical Stocks

Investment News Show

To Feature Small Cap Medical Stock With Increasing Revenues.

The small cap stocks to buy coverage includes an interview with undervalued medical stock, RMS Medical Products, Inc. (Stock Symbol: REPR) President and Chairman of the Board of Directors Andrew Sealfon.

RMS Medical Products, Inc.

(Stock Symbol: REPR

Visit the corporate website: http://www.rmsmedicalproducts.com

For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link: http://finance.yahoo.com/q?s=repr

Listen to a replay of Part 1 of the show:

Options Trading Strategies October 2014

Listen to a replay of Part 2 of the show

With REPR CEO, Andy Sealfon Interview :

Stocks To Buy October 2014

Undervalued Medical Stocks To Buy

Small Cap Medical Stock News

Stocks To Buy October 2014 

REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.

STRONG GROWTH CONTINUES

REPR Annual Revenue and Profits Continue To Increase

New health insurance changes are forcing more and more home health care – A sector in which REPR excels.

Medical Growth Stock

Sales for the FREEDOM 60® pump continue to produce spectacular grow.

RMS Medical Products specializes in developing and manufacturing portable medical devices,  understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.

With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.

Primary products are: 

FREEDOM60® Syringe Infusion System –  Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs. 

RES-Q-VAC® Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.

RMS HIGH-Flo™  Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.

 See more product information at

http://www.rmsmedicalproducts.com/?node=products

 

September 23, 2014 Show:

Radiation Exposure Treatment

Medical Stocks To Buy

Featured on Money Info Show 

The September 22, 2014 Money Info Investment news and small cap stocks to buy show featured a live interview with:

Rachel Levine, Vice President, Investor Relations

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Part 1 of the show

Options Trading Strategies | Options Trading Newsletter

 

Part 2 of the Show:

Radiation Exposure Treatment Medical Stocks To Buy

 

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

Innovative Drugs To Treat Cancer

Buffalo, NY – September 3, 2014 – Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced that the minutes from its meeting with the U.S. Food and Drug Administration (FDA) in July confirmed that the Company’s existing efficacy and safety data and animal-to-human dose conversion are sufficient to proceed with a pre-Emergency Use Authorization (pre-EUA) submission for entolimod for reducing the risk of death following exposure to potentially lethal irradiation occurring as the result of a radiation disaster.

See more at:

http://www.princetonresearch.com/medical-stock-news-cbli/

Small cap medical stocks

Radiation Exposure Treatment Drugs

Stock News

Just imagine the catastrophe if radioactive material falls into the wrong hands. The Russians have invested heavily in this.  CBLI is involved in the development of Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment, and Curaxin CBL0137, the lead oncology product candidate.

The company conducts business in the United States and in the Russian Federation through our three operating subsidiaries, Incuron, LLC, BioLabs 612, LLC and Panacela Labs, Inc. The company maintains strategic relationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia.

To learn more about Cleveland BioLabs, Inc., please visit the Company’s website at http://www.cbiolabs.com.

 

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

See news

 

45%+ Upward Movement — See Report

 

Small Cap Medical Stock News:

Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer CBLB612

–  See News Here and http://irdirect.net/pr/release/id/886944

 

Cleveland BioLabs CEO Presents at FDA Update Conference

-See Transcript

 

Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for Entolimod

See News

September 16, 2014 Show:

Water Stocks | Best Water Stocks to Buy

Part 1 of the Show:

Options Trading Newsletter

Part 2 of the Show:

Small Cap Water Tech Stocks to Buy

The show featured a live interview with small cap water stock to buy

WATER TECHNOLOGIES INTERNATIONAL INC.

Chairman and CEO Scott Tudor

Stock Symbol: WTII

See Corporate Site: gr8water.net

Get Stock Quote and Latest News – Click Here

 

“We will not know the worth

of water ’til the well is dry”

Water Stocks To BUY

Water Technologies International, Inc., (WTII) is comprised of three wholly owned subsidiaries.

GR8 Water, Inc., (Great Water) is focused on home and office, as well as large commercial AWG’s (Atmospheric Water Generators).

The second wholly owned subsidiary is Aqua Pure International, Inc., a Florida corporation that is focused on filtration devices for the AWG’s.

The third wholly owned subsidiary is Water Technologies International, LLC, a Florida limited liability company.

All of the associated companies are in the business of designing, manufacturing, and distributing Atmospheric Water Generators (AWG’s) and related products.

Small Cap Water Stocks to BUy

Water Technologies International (GR8 Water) is engaged in the manufacture and distribution of technologically advanced Atmospheric Water Generators (AWG).  These unique devices utilize a patent pending air purification input system to produce clean, great-tasting, safe water from the humidity in the air.

GR8 Water makes freestanding water factory units for the home or office and large, industrial-sized water units using a modular design that can produce up to thousands of gallons of water each day from ambient air.

Water Tech Stock

 

GR8 Water strives to make safe drinking water available to everyone on the planet, making the world a better place in which to live while nurturing the environment.

Tech Stocks to Buy

 Water Stock News

September 9, 2014 Show:

September 2014 Stocks To Buy

September 9, 2014 Money Info Show to feature medical stocks to buy.

The Show was broadcast on Google hangouts.

Replay of the show

Part 1 

Options Trading | How To Trade Options

Options trading, how to trade options and options trading strategies that work will be covered on the September 9 broadcast of the Money Info Stock Market News Today Radio Show.

Part 2 of the Show

Best Stocks To Buy

Cancer Treatment Medical Stock News

 

Money Info Show featured in the news:

Stock Market News Today Radio Show Features Medical Stock News, Options Trading and Best Stocks To Buy Now

http://www.free-press-release-center.info/previewrelease.php?rid=00000000000000282209

and

Best Stocks To Buy CBLI Biotech Medical Stock To Be Featured On Where to invest Now Money info Show

http://www.pr-inside.com/best-stocks-to-buy-cbli-biotech-r4112691.htm

 

NOTE: Ms Levine was unable to attend the live broadcast.

It is rescheduled for next Tuesday, September 16th.

The show was to feature a live interview with

Rachel Levine, Vice President, Investor Relations

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Cleveland BioLabs (CBLI) Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

Innovative Drugs To Treat Cancer

Buffalo, NY – September 3, 2014 – Cleveland BioLabs, Inc. (NASDAQ:CBLI) today announced that the minutes from its meeting with the U.S. Food and Drug Administration (FDA) in July confirmed that the Company’s existing efficacy and safety data and animal-to-human dose conversion are sufficient to proceed with a pre-Emergency Use Authorization (pre-EUA) submission for entolimod for reducing the risk of death following exposure to potentially lethal irradiation occurring as the result of a radiation disaster.

See more at:

http://www.princetonresearch.com/medical-stock-news-cbli/

CBLI Stock News: Cleveland BioLabs stock soars –

Shares Up Big After Report Of

Positive FDA Opinion Issued For

Entolimod, Cancer Treatment And

Radiation Countermeasure Drug

Best Stocks To Buy

• Shares of small cap medical stock, Cleveland BioLabs (CBLI +49.3%) leap on a considerable 23x surge in volume. The small cap medical stock reported that its existing safety and efficacy data and animal-to-human dose conversion are enough to proceed with a pre-Emergency Use Authorization submission to the FDA for the use of entolimod to reduce the risk of death following radiation exposure.

 

• The company’s opinion is based on the minutes from its July meeting with the agency. Regulatory approval will allow the use of entolimod in the occurrence of a radiological or nuclear emergency.

 

• In a study involving 179 non-human primates, a single IM shot of entolimod administered 25 hours following whole-body irradiation improved survival from 27.5% to 75%.

See more at:

http://seekingalpha.com/pr/10911025-cleveland-biolabs-announces-green-light-to-submit-pre-emergency-use-authorization-application-for-entolimod

 

More penny stocks to buy news:

Cleveland BioLabs Announces

Green Light to Submit

Pre-Emergency Use Authorization Application for Entolimod

BUFFALO, NY — (Marketwired) — 09/03/14 — Cleveland BioLabs, Inc. (CBLI(NASDAQ: CBLI) today announced that the minutes from its meeting with theU.S. Food and Drug Administration (FDA) in July confirmed that the Company’s existing efficacy and safety data and animal-to-human dose conversion are sufficient to proceed with a pre-Emergency Use Authorization (pre-EUA) submission for entolimod for reducing the risk of death following exposure to potentially lethal irradiation occurring as the result of a radiation disaster.

 top stocks to buy

Cleveland BioLabs Provides

Medical Countermeasures Against

Probable Terrorist Attacks

Terrorism is a real threat to America’s homeland as we have seen in recent news. However, we can take a little solace in the truth that the recent terrorist strike involved crude homemade non-radiological bombs. The fact remains that the world we are in is under constant threat from larger terrorist attacks, namely the sort that could involve “dirty bombs”.

A dirty bomb is a radiological weapon that includes radioactive material with typical explosives. Obviously, the aim of such a disgusting weapon is usually to inflict as much radioactive poisoning upon human beings as possible. In an effort to there will be the damage a radiological weapon might inflict around the American people, the United states Government began providing money to certain developmental firms.

One company that your U. S. Government possesses provided money to pertaining to developing radiological countermeasures is Cleveland BioLabs (NASDAQ: CBLI).

Cleveland BioLabs, is a developmental stage biopharmaceutical company aiming to treat cancer, prevent as well as treat acute radiation affliction (ARS), and counteract your toxic effects of airwaves and chemotherapies for oncology individuals. Let’s delve a little deeper into this interesting biotech company, along with others linked to preventative measures against prospective attacks.

small cap stocks to buy

The “Project BioShield Act” had been enacted on July 21 years old, 2004, as part of a broad strategy to support defend America against tools of mass destruction. Our elected representatives appropriated $5. 6 billion towards the Project BioShield Special Reserve Fund to guide the research, development, as well as acquisition of priority medical countermeasures against chemical, neurological, nuclear, and radiological (CBRN) threats. The Biomedical Advanced Study and Development Authority (BARDA)is the arm on the U. S. Department of Health insurance and Human Services charged along with allocating the funds. In a underreported development, Congress not too long ago earmarked additional funds pertaining to BARDA. The Pandemic as well as All-Hazards preparedness Reauthorization Act of 2013 was simply just signed into law on March 13th, designating one more $2. 8B for catastrophe related drug research as well as development.

Small cap medical stocks

In September of recently, BARDA awarded up in order to $106 million to Cytori Therapeutics (NASDAQ: CYTX) to develop cell therapies for winter burns and radiation harm. The aim of this deal was to evaluate and create new countermeasures pertaining to widespread thermal burns from mass casualty event like we saw in Fukushima inside 2011. For a company with a market cap of just $166 million and limited sources of revenue, a contract this large is important in furthering development associated with existing and possible future therapies which may potentially grow the business.

Best Stocks To Buy

September 2, 2014 Show:

Oil Project Investing News Show

Small Cap Oil Stocks To Buy

Oil Project Investment

Target Energy, Ltd.

Featured On

Money Info Investing News Show

Part 1 of the show covers options trading strategies, stock options text message trading alerts service and stock market news today. 

 

Part 2 with Laurence Roe interview
Oil Stock Investing News

In OTCBB energy and oil company stock news the September 2, 2014 Money Info Investment News show features a live interview with

Laurence Roe, Managing Director

of domestic oil & gas production company,

Target Energy, Ltd.

Stock SymbolTEXQY

See Target Energy Ltd. corporate website: http://www.targetenergy.com.au

Get TEXQY Quotes and Trading Charts on Yahoo Finance:

http://finance.yahoo.com/q?s=TEXQY

Oil Stocks To Buy

Target Energy represents an undervalued oil stock to buy and an opportunity to invest in producing oil projects company.

Target’s performance and quarterly oil & gas production rates is growing faster then their market cap.

Oil Stock Investing News

Target Energy Corporate Presentation August 2014

Aug 11th 2014

Target Energy Fairway Project Update

Aug 11th 2014

Target Energy Quarterly Report 30 June 2014

Jul 31st 2014

For More Oil Investing News on

Target Energy — Click Here

oil and gas stock investment

Click Here To Get Updates

Texas oil investing news

Target Energy is a U.S. focused domestic oil and gas exploration and production company. The company has assets in the Permian Basin, West Texas and in the Texas and Louisiana Gulf Coasts.

An overview of the Texas oil and gas production company Target Energy Limited (OTCQX: TEXQY) (ASX: TEX) stock investment opportunity, including recent operations updates and developments at their Fairway Project in West Texas will be presented on the show.

Oil Project investing news

Well production rates for the company’s 

properties can be seen at:

http://www.targetenergy.com.au/viewStory/project/Overview

In accordance with ASX Listing Rules, any hydrocarbon reserves and/or drilling update information in this report has been reviewed and signed off by Mr. Laurence Roe, BSc, Managing Director of Target Energy, who is a member of the Society of Exploration Geophysicists and has over 30 years’ experience in the sector. He consents to that information in the form and context in which it appears.

About Target Energy Limited:

Target Energy Ltd is an oil and gas exploration and production company listed on the Australian Securities Exchange and trading under the symbol “TEX”. The company is listed in the U.S. via the OTCQX platform under the symbol “TEXQY”.

Target’s business strategy is to acquire meaningful acreage leaseholds in US onshore hydrocarbon basins which contain significant untapped oil and gas reserves. The company has assets in the Permian Basin, West Texas and in the Texas and Louisiana Gulf Coasts.

The corporate growth objective is to grow production, reserves, cash flow and shareholder value through a comprehensive drilling program which utilizes current oilfield technology in both conventional and unconventional oil resource plays.

August 19, 2014 Show:

Mining Stocks To Buy 

On MONEY INFO

Investment News SHOW

The show was broadcast on Google hangouts and Youtube

Where to Invest Now Money Info Show

Mining Stocks to Buy

The show featured mining stocks to buy news on gold mining company:

XIMEN MINING CORP 

Stock Symbol: XIM

including a live interview with

Christopher R. Anderson,

President, CEO and Director of

Ximen Mining Corp.

Corporate Site: ximenminingcorp.com

For XIM Quotes, Trading Charts and News at Yahoo Finance:

Click Here

Facebook Page: https://www.facebook.com/pages/Ximen-Mining-Corp/572715196119908

Mining Stocks to Buy

Ximen Mining Corp. owns 100% interest in its 2 gold mining projects:

Gold Drop Project and Brett Gold Project located in southern British Columbia.

Recently the company has entered into a due diligence agreement with Huldra Silver Inc. for the purposes of determining the feasibility, terms and conditions of a proposal for the acquisition of Huldra Silver.

Ximen is a publicly listed company trading on the TSX Venture Exchange under the symbol XIM, and is listed on the Frankfurt, Munich, and Berlin Stock Exchanges in Germany under the symbol 1XM and WKN number is A1W2EG.

For XIM on Google Finance – Click Here

Mining Stock news

Gold Mining Stocks To Buy Latest News:

Ximen Commences IP Survey on the Brett Gold Property, Vernon, BC — See news

First Tranche of Ximen Private Placement Closed — See news

Ximen’s Sample Results From the Exploration Program on Gold Drop Property, Greenwood, BC — See news

 

August 12, 2014 Show:

Innovative Drugs To Treat Cancer

Best Stocks To Buy August 2014

Medical Stock News

on Money Info Investment News Show

The show featured a live interview with

Rachel Levine, Vice President, Investor Relations

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: cbiolabs.com

Investors Conference Call Transcript — Click Here

Financials News – Click Here

Part 1 of the show:

Best Stocks To Buy August 2014 Undervalued Medical Stock News

Part 2 of the Show with CBLI Interview:

Innovative Drugs To Treat Cancer

Small Cap Medical Stock News

Developing and commercializing

innovative drugs to

treat cancer and orphan diseases and

protect healthy tissues.

Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need.

Small cap medical stocks

The company’s lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate.

CBL0137 is under development by Incuron, LLC, a Russian Federation based joint venture founded in 2010 between Russian Closed Mutual Venture Fund “Bioprocess Capital Ventures,” and Cleveland BioLabs.

undervalued healthcare stocks 2014

Cleveland BioLabs, Inc. conducts business in the United States and in the Russian Federation through its wholly and majority owned operating subsidiaries.

The company maintains strategicrelationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia for Medical Research.

medical stocks to buy in 2014

To learn more about Cleveland BioLabs, Inc. 

visit the Company’s website at CBIOLabs.com

To learn more about Incuron, LLC

visit the company’s website at Incuron.com.

Medical Stocks To Buy

See more at Yahoo Finance Small Cap Medical Stock News

small cap stocks to buy

Medical Stocks In The News

Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock

(Marketwired – Jun 18, 2014) – Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the “Purchase Agreement”) with Dr. Mikhail Mogutov, Chairman of the Board of Directors of Incuron, LLC and Chairman of the Investment Committee and founder of Bioprocess Capital Ventures and one institutional investor (the “Investors”), to issue and sell in a private placement $3.5 million worth of the Company’s common stock, par value $.005 per share (the “Common Stock”),and warrants to purchase Common Stock.

See More

Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “This transaction deepens our strategic relationship with Dr. Mogutov. We appreciate his continued support of our science and development pipeline. These proceeds enable us to reduce the debt on our balance sheet by two-thirds, favorably impacting our cash runway.”

medical stocks to buy now

 

 

August 5, 2014 Show:

Small Cap Medical Stocks

On Investing News Show

Small Cap Medical Stocks

Investment News Show

Features Small Cap Medical Stock With Increasing Revenues.

RMS Medical Products, Inc.

(Stock Symbol: REPR

Medical Small Cap Stocks

Visit the corporate website: http://www.rmsmedicalproducts.com

For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link: http://finance.yahoo.com/q?s=repr

 

Part 1 of the show

Undervalued Small Cap Stocks To Buy

Part 2 of the show:

Undervalued Medical Stocks To Buy

Small Cap Medical Stock News

REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.

STRONG GROWTH CONTINUES

REPR Annual Revenue and Profits Continue To Increase

10-Q Filing for the Quarter Ended May 31, 2014

Medical Growth Stock

Click Image To Enlarge

New health insurance changes are forcing more and more home health care – A sector in which REPR excels.

Medical Growth Stock

Sales for the FREEDOM 60® pump continue to produce spectacular grow.

RMS Medical Products specializes in developing and manufacturing portable medical devices,  understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.

With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.

Primary products are: 

FREEDOM60® Syringe Infusion System –  Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs. 

RES-Q-VAC® Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.

RMS HIGH-Flo™  Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.

 See more product information at

http://www.rmsmedicalproducts.com/?node=products

 

July 22, 2014 Show:

Oil Investing News and Oil Stocks To Buy 

Small Cap Oil Stocks To Buy

Oil Production Investment

Target Energy, Ltd.

Featured On

Money Info News Radio Show

In OTCBB energy and oil company stock news the July 22, 2014 Money Info Investment News radio show features a live interview with

Laurence Roe, Managing Director

of domestic oil & gas production company,

Target Energy, Ltd.

Stock SymbolTEXQY

Replay of the show Part 1: 

Texas Oil InvestingOil Stocks To Buy News

 

Replay of the show Part 2 with interview:

Oil and Gas Production Companies

See Target Energy Ltd. corporate website: http://www.targetenergy.com.au

Get TEXQY Quotes and Trading Charts on Yahoo Finance:

http://finance.yahoo.com/q?s=TEXQY

 

Oil Investing News

Sale of 10% Interest in Fairway Project

for $5,800,000 Underway – See More

 

Fairway Oil Production Property Acquisition

By Victory Energy Corporation Expected

To Close June 30, 2014 – See More

 

For More Oil Investing News on

Target Energy — Click Here

oil and gas stock investment

Click Here To Get Updates

Texas oil investing news

Target Energy is a U.S. focused domestic oil and gas exploration and production company. The company has assets in the Permian Basin, West Texas and in the Texas and Louisiana Gulf Coasts.

An overview of the Texas oil and gas production company Target Energy Limited (OTCQX: TEXQY) (ASX: TEX) stock investment opportunity, including recent operations updates and developments at their Fairway Project in West Texas will be presented on the show.

Oil Project investing news

Well production rates for the company’s 

properties can be seen at:

http://www.targetenergy.com.au/viewStory/project/Overview

In accordance with ASX Listing Rules, any hydrocarbon reserves and/or drilling update information in this report has been reviewed and signed off by Mr. Laurence Roe, BSc, Managing Director of Target Energy, who is a member of the Society of Exploration Geophysicists and has over 30 years’ experience in the sector. He consents to that information in the form and context in which it appears.

About Target Energy Limited:

Target Energy Ltd is an oil and gas exploration and production company listed on the Australian Securities Exchange and trading under the symbol “TEX”. The company is listed in the U.S. via the OTCQX platform under the symbol “TEXQY”.

Target’s business strategy is to acquire meaningful acreage leaseholds in US onshore hydrocarbon basins which contain significant untapped oil and gas reserves. The company has assets in the Permian Basin, West Texas and in the Texas and Louisiana Gulf Coasts.

The corporate growth objective is to grow production, reserves, cash flow and shareholder value through a comprehensive drilling program which utilizes current oilfield technology in both conventional and unconventional oil resource plays.

Where To Invest Now March 2014 Market Strategies

Target has been successful in securing acreage in the prolific and highly sought-after Permian Basin in West Texas. The company currently has four producing wells in this holding and an active forward drilling program.

See the Target Energy Ltd. corporate website (http://www.targetenergy.com.au) for more information on the company, oil & gas drilling projects, well production, stock quotes, trading charts and the most recent corporate news.

Oil Stocks To Watch

 

 

July 15, 2014 Show:

Small Cap Medical Stock News

The July 15th Money Info Show will feature a live interview with

Neil Lyons,CFO of Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI).

Corporate Site: cbiolabs.com

Developing and commercializing

Innovative Drugs To

Treat Cancer

and orphan diseases and

protect healthy tissues.

Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need.

Small cap medical stocks

The company’s lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate.

CBL0137 is under development by Incuron, LLC, a Russian Federation based joint venture founded in 2010 between Russian Closed Mutual Venture Fund “Bioprocess Capital Ventures,” and Cleveland BioLabs.

Cleveland BioLabs, Inc. conducts business in the United States and in the Russian Federation through its wholly and majority owned operating subsidiaries.

Medical Stocks To Buy

The company maintains strategicrelationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia for Medical Research.

To learn more about Cleveland BioLabs, Inc. 

visit the Company’s website at CBIOLabs.com

To learn more about Incuron, LLC

visit the company’s website at Incuron.com.

undervalued healthcare stocks 2014

See more at Yahoo Finance Small Cap Medical Stock News

 

About Neil Lyons, CPA — Chief Financial Officer

Mr. Lyons joined Cleveland BioLabs as Chief Financial Officer in 2011.

He has more than 30 years of experience in operations, finance, strategy, SEC compliance, information systems and corporate governance in both public and private companies.

Prior to joining the Company, Mr. Lyons served as Chief Financial Officer, Secretary and Treasurer of RegeneRx Biopharmaceuticals, Inc, where he led several financial transactions, influenced clinical/corporate strategy, identified and captured government grant opportunities, directed investor relations, developed financial models and implemented investment strategies and employee benefit programs.

 

Medical Stocks In The News

Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock

(Marketwired – Jun 18, 2014) – Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the “Purchase Agreement”) with Dr. Mikhail Mogutov, Chairman of the Board of Directors of Incuron, LLC and Chairman of the Investment Committee and founder of Bioprocess Capital Ventures and one institutional investor (the “Investors”), to issue and sell in a private placement $3.5 million worth of the Company’s common stock, par value $.005 per share (the “Common Stock”), and warrants to purchase Common Stock.

See More

Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “This transaction deepens our strategic relationship with Dr. Mogutov. We appreciate his continued support of our science and development pipeline. These proceeds enable us to reduce the debt on our balance sheet by two-thirds, favorably impacting our cash runway.”

medical stocks to buy now

 

July 8, 2014 Show:

Undervalued Medical Stocks

Small Cap Stocks to Buy

On

Money Info Show

Replay of the Show Part 1:

Undervalued Medical Stocks

Replay of the Show Part 2 with live interview:


Medical stocks to buy

The show featured a live interview with

Rachel Levine, Vice President, Investor Relations

Cleveland BioLabs, Inc.

(NASDAQ Stock Symbol: CBLI)

Corporate Site: http://www.cbiolabs.com

Small Cap Medical Stock News

Developing and commercializing

innovative drugs to

treat cancer and orphan diseases and

protect healthy tissues.

Cleveland BioLabs, Inc. is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need.

Small cap medical stocks

The company’s lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate.

CBL0137 is under development by Incuron, LLC, a Russian Federation based joint venture founded in 2010 between Russian Closed Mutual Venture Fund “Bioprocess Capital Ventures,” and Cleveland BioLabs.

undervalued healthcare stocks 2014

Cleveland BioLabs, Inc. conducts business in the United States and in the Russian Federation through its wholly and majority owned operating subsidiaries.

The company maintains strategicrelationships with the Cleveland Clinic, Roswell Park Cancer Institute, and the Children’s Cancer Institute Australia for Medical Research.

medical stocks to buy in 2014

To learn more about Cleveland BioLabs, Inc. 

visit the Company’s website at CBIOLabs.com

To learn more about Incuron, LLC

visit the company’s website at Incuron.com.

 Medical Stocks To Buy

See more at Yahoo Finance Small Cap Medical Stock News

small cap stocks to buy

Medical Stocks In The News

Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock

(Marketwired – Jun 18, 2014) – Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it entered into a securities purchase agreement (the “Purchase Agreement”) with Dr. Mikhail Mogutov, Chairman of the Board of Directors of Incuron, LLC and Chairman of the Investment Committee and founder of Bioprocess Capital Ventures and one institutional investor (the “Investors”), to issue and sell in a private placement $3.5 million worth of the Company’s common stock, par value $.005 per share (the “Common Stock”),and warrants to purchase Common Stock.

See More

Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “This transaction deepens our strategic relationship with Dr. Mogutov. We appreciate his continued support of our science and development pipeline. These proceeds enable us to reduce the debt on our balance sheet by two-thirds, favorably impacting our cash runway.”

medical stocks to buy now

 

 

July 1, 2014 Show:

Oil Investing News

Tree Top Industries, Inc.

(Stock Symbol: TTII

On Money Info Show

The show featured a  live interview with Tree Top Industries, Inc. (TTII) CEO David Reichman.

small cap stocks to buy

Corporate Site: www.TTTIob.com

Part 1 of the show:

Part 2 (with Tree Top Industries, Inc. (Stock Symbol: TTII) CEO David Reichman interview) of the show:

Tree Top Industries, Inc. (TTII)

is a publicly traded mini conglomerate.

Tree Top subsidiaries and affiliates include intellectual properties, proprietary systems, and trade secrets in the bioscience and global health technology fields, among other new and emerging technologies, as well as interests in the oil and gas industries. Tree Top can provide the protective umbrella of a publicly listed, SEC compliant, PCAOB audited company to acquisition candidates, as well as structure, transparency, potential capital raise and growth potential.

Small Cap Oil Stocks In The News 

The Tree Top subsidiary, TTII Oil & Gas, Inc., a Delaware corporation, acquired all of the assets of American Resource Technologies, Inc. (ARUR).

During the show Mr. Reichman will discuss new developments in the TTII Oil & Gas Production subsidiary.

Small cap oil stock news

Cumulative oil production in Southeastern Kansas has shown storng growth.

small cap stocks to watch

 The Company’s expansion includes participation in two U.S. owned Brazilian companies as well as the 25% stake in a firm that has designed the new software, allowing the interpretation of data acquired via aerial or surface surveys.  Through this information the Company can produce a 3D blueprint with the highest concentration of hydrocarbons in these areas.

Tree Top can also deliver the means, though incubation, for private companies to become public entities in good standing. Tree Top is in the development stage, actively acquiring companies and technologies using several different business paradigms, including exchange of stock, joint venture, and other partnership configurations.

Small Cap tech stock

The Company also NetThruster, Inc. (NetThruster).


Money Info Show


Replay Archives

Hear Replays of

July and June 2014 Shows

Click Here

 

Hear Replays of

May, April and March 2014 Shows

Click Here

Hear Replays of

January and February 2014 Shows

Click Here

 

Hear Replays of

December and November 2013 Shows

Click Here

Hear Replays of October 2013 Shows

Click Here

Hear Replays of September 2013 Shows:

Click Here

Hear Replays of August 2013 Shows

Click Here

June 2013 and July 2013

Money Info Show Replays

Click Here

 

April 2013 and May 2013

Money Info Show Replays

Click Here

 

March 2013 and February 2013

Money Info Show Replays

Click Here

 

January 2013

Money Info Show Recaps

Click Here

 

December 2012

Money Info Show Replays

Get Recaps of December Shows

 

November 2012

Money Info Show Replays

Get recaps of November Shows


October 2012

Money Info Show Replays

Get recaps of October Shows

 

September 2012

Money Info Show Replays

See past show recaps

 

Money Info

The Princeton Research Money Info Show features where to invest now,

stock market, business, economy and

financial investment news.

Money Info is hosted by Mike King, Charles Moskowitz, Oscar Carboni and K. C. Quintana.

 

Stock Options Trading Alerts Update:

In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.

See http://www.princetonresearch.com/options-trading.htm to get in today.

Money Info

Money Info Investment News Show